International Immunopharmacology

Scope & Guideline

Pioneering Insights in Immunopharmacological Research

Introduction

Welcome to the International Immunopharmacology information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of International Immunopharmacology, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1567-5769
PublisherELSEVIER
Support Open AccessNo
CountryNetherlands
TypeJournal
Convergefrom 2001 to 2024
AbbreviationINT IMMUNOPHARMACOL / Int. Immunopharmacol.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS

Aims and Scopes

The journal 'International Immunopharmacology' focuses on the intersection of immunology and pharmacology, addressing how immune responses can be modulated through pharmacological interventions. It aims to publish high-quality research that enhances our understanding of immune mechanisms and their implications for therapeutic strategies.
  1. Immunomodulation:
    The journal emphasizes research that explores how various agents, including drugs and biologics, can modulate the immune system, enhancing or suppressing immune responses for therapeutic purposes.
  2. Inflammation and Disease:
    A core area of focus is the role of inflammation in various diseases, including autoimmune disorders, cancer, and infectious diseases, and how pharmacological agents can alter inflammatory pathways.
  3. Biomarkers and Therapeutics:
    The identification and validation of biomarkers related to immune responses and the therapeutic efficacy of treatments are critical aspects of the journal's scope.
  4. Translational Research:
    The journal encourages studies that bridge basic immunological research with clinical applications, aiming to translate findings into effective treatments for patients.
  5. Novel Therapeutic Approaches:
    There is a strong emphasis on innovative therapeutic strategies, including the use of stem cells, nanoparticles, and biologics in immunotherapy and pharmacotherapy.
The journal is witnessing emerging themes that reflect current challenges and advancements in the field of immunopharmacology. These trends indicate areas of growing research interest and potential future directions for exploration.
  1. Immunotherapy Innovations:
    There is a clear trend towards innovative immunotherapeutic strategies, including CAR-T cell therapies and checkpoint inhibitors, reflecting the rapid advancements in cancer treatment.
  2. Microbiome and Immune Interactions:
    Research exploring the gut microbiome's role in modulating immune responses and its implications for various diseases has gained significant traction.
  3. Ferroptosis and Other Regulated Cell Death Pathways:
    Studies focusing on ferroptosis and other forms of regulated cell death are emerging as critical areas of interest, particularly concerning their implications for cancer and autoimmune diseases.
  4. Nanoparticle-Based Drug Delivery Systems:
    The application of nanoparticles in drug delivery and immunomodulation is trending, highlighting their potential in enhancing therapeutic efficacy while minimizing side effects.
  5. Personalized Medicine Approaches:
    There is a growing emphasis on personalized medicine, with research increasingly focusing on tailoring immunotherapies based on individual patient biomarkers and genetic profiles.

Declining or Waning

As the field of immunopharmacology evolves, certain research themes may be declining in frequency or importance within recent publications. This section highlights those areas that appear to be waning based on the latest trends in the journal's output.
  1. Traditional Pharmacological Approaches:
    There seems to be a decreasing emphasis on classical pharmacological methods without immunological considerations, as newer, more integrated approaches are favored.
  2. Basic Immunology without Clinical Application:
    Research that does not connect basic immunological findings to clinical applications or therapeutic strategies appears to be less represented, reflecting a shift towards translational research.
  3. Monotherapy Studies:
    There is a notable decline in studies focusing solely on monotherapy outcomes, with a preference for combination therapies that address complex disease mechanisms.
  4. In vitro Studies without In Vivo Validation:
    Research that solely relies on in vitro models without subsequent in vivo validation is becoming less common, as the journal prioritizes studies that demonstrate practical therapeutic relevance.

Similar Journals

PARASITE IMMUNOLOGY

Transforming Understanding of Parasitic Diseases.
Publisher: WILEYISSN: 0141-9838Frequency: 12 issues/year

PARASITE IMMUNOLOGY, published by Wiley, is a leading journal in the field of immunology and parasitology, with an ISSN of 0141-9838 and E-ISSN of 1365-3024. Since its inception in 1979, it has played a pivotal role in advancing our understanding of host-parasite interactions, immunological responses to parasitic infections, and the mechanisms of immunological resistance. The journal is adeptly positioned within the academic community, currently holding a prestigious Q2 ranking in Parasitology and a Q3 ranking in Immunology for 2023, indicating its significant influence and relevance. Its comprehensive scope attracts a diverse readership, contributing to the discourse surrounding novel therapeutic approaches and emerging challenges in parasitic diseases. With a consistent convergence of research until 2024, PARASITE IMMUNOLOGY is an essential resource for researchers, professionals, and students seeking to deepen their knowledge and foster collaboration in these dynamic fields. Although it is not an open-access journal, the insights shared within its pages are invaluable for shaping future research trajectories.

IMMUNOLOGICAL INVESTIGATIONS

Advancing Immunology Through Rigorous Research
Publisher: TAYLOR & FRANCIS INCISSN: 0882-0139Frequency: 8 issues/year

IMMUNOLOGICAL INVESTIGATIONS, published by Taylor & Francis Inc, is a leading journal in the field of immunology and related medical sciences, with an established presence since 1972. With a focus on cutting-edge research and critical insights in immunological methods and theories, this journal serves as a pivotal platform for researchers, professionals, and students alike. Though it currently holds a Q3 ranking in Immunology and a Q2 ranking in miscellaneous medicine as of 2023, its Scopus rank of #129 out of 236 reflects its dedication to advancing the understanding of immune responses and therapies. The journal's commitment to rigorous peer review and high-quality publications enables it to remain relevant and influential in the ever-evolving landscape of immunological research. Subscription is required to access its extensive archive, which spans critical developments in the field of immunology from 1972 to 2024.

SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Innovative Discoveries Shaping the Future of Immunology
Publisher: WILEYISSN: 0300-9475Frequency: 12 issues/year

Scandinavian Journal of Immunology is a prestigious peer-reviewed journal published by Wiley, focused on the evolving field of immunology and its interdisciplinary ties with medicine. Since its inception in 1972, this journal has cultivated a rich repository of knowledge, showcasing innovative research and reviews that contribute to the understanding of immune system functions, disorders, and therapeutic interventions. With an impressive impact factor reflecting a Q2 ranking in Immunology and a top-tier Q1 status in miscellaneous Medicine categories for 2023, it is recognized for its high-quality scholarly output, positioning it among the leading journals in the field. Additionally, its Scopus ranking of #84 out of 236 in Immunology underscores its significance and relevance to both emerging and established researchers. Although it does not currently offer open access options, the journal’s expansive reach and rigorous publication standards make it an essential platform for disseminating impactful research to the global scientific community. The journal invites submissions that explore the complexities of the immune system, aiming to bridge clinical and basic science for a comprehensive understanding of immunological phenomena.

INTERNATIONAL IMMUNOLOGY

Elevating the Standards of Immunological Research Worldwide.
Publisher: OXFORD UNIV PRESSISSN: 0953-8178Frequency: 12 issues/year

INTERNATIONAL IMMUNOLOGY, published by OXFORD UNIV PRESS, stands out as a premier journal in the field of immunology, providing a vital platform for disseminating groundbreaking research and innovative developments within the discipline. With an impressive Q1 ranking in Immunology and Allergy, as well as in Medicine (miscellaneous), it consistently showcases high-impact studies that contribute to the advancement of immunological knowledge. The journal spans over three decades, from its inception in 1989 to its ongoing contributions as of 2024, thus solidifying its reputation in the scientific community. Researchers, professionals, and students will find valuable articles that delve into the complexities of immune responses, therapeutic interventions, and emerging immunological paradigms, ensuring INTERNATIONAL IMMUNOLOGY remains at the forefront of knowledge in the life sciences.

Journal of Immunology Research

Connecting Researchers: Elevating the Study of Immunology Worldwide
Publisher: HINDAWI LTDISSN: 2314-8861Frequency:

Journal of Immunology Research, published by HINDAWI LTD, stands as a pivotal open-access journal in the realm of immunology, with a particular emphasis on advancing knowledge in both fundamental and applied aspects of the field. Since its inception in 1990, the journal has committed to the dissemination of high-quality research, earning a respectable impact factor that reflects its significance. Based in Egypt, it provides a platform for researchers from around the world, showcasing innovative studies and reviews that contribute to the understanding of immune system mechanisms. Its 2023 rankings place it in the Q2 category for Immunology and Allergy, and Q1 in the broader category of Medicine (miscellaneous), indicating a strong reputation among its peers. Through its open-access model, the journal promotes wide accessibility of cutting-edge research, catering to researchers, professionals, and students alike. With ambitions that converge through 2024, the Journal of Immunology Research continues to be an essential resource for those seeking to explore the forefront of immunological science.

MOLECULAR ASPECTS OF MEDICINE

Pioneering Research for a Healthier Tomorrow
Publisher: ELSEVIERISSN: 0098-2997Frequency: 6 issues/year

MOLECULAR ASPECTS OF MEDICINE is a premier journal published by Elsevier, focusing on groundbreaking research in the fields of biochemistry, molecular biology, and medicine. With an impressive impact factor and ranking within the top quartile across multiple categories, including Q1 in Biochemistry, Clinical Biochemistry, and Molecular Medicine, it serves as an essential platform for sharing innovative findings that advance our understanding of molecular mechanisms in health and disease. The journal, which has been in publication since 1976, provides a diverse range of articles, addressing both fundamental and applied aspects of molecular medicine, thus appealing to a broad audience of researchers, professionals, and students. While MOLECULAR ASPECTS OF MEDICINE does not currently offer Open Access options, it remains a vital resource for accessing high-quality, peer-reviewed scholarly works that significantly contribute to the advancement of biomedical research.

Science Immunology

Pioneering Insights in Immunology and Health
Publisher: AMER ASSOC ADVANCEMENT SCIENCEISSN: 2470-9468Frequency: 12 issues/year

Science Immunology, published by the American Association for the Advancement of Science, is a leading journal in the field of immunology, recognized for its significant impact and rigor in advancing our understanding of immune responses and complex diseases. With an impressive impact factor that places it in the Q1 category of both immunology and allergy, as well as miscellaneous medicine, this journal is ranked #7 and #8 in their respective Scopus categories, reflecting its high-quality research output. Since its inception in 2016, Science Immunology has been at the forefront of interdisciplinary immunological research, fostering crucial insights that link immunology with pressing health challenges. The journal is committed to providing open access to its content, ensuring that groundbreaking findings are accessible to a global audience of researchers, professionals, and students. Its anthology not only addresses fundamental immunological mechanisms but also enhances the dialogue on translational applications and therapeutic interventions, solidifying its position as an essential resource within the scientific community.

Journal of Neuroimmune Pharmacology

Advancing the Frontiers of Neuroimmune Research
Publisher: SPRINGERISSN: 1557-1890Frequency: 4 issues/year

The Journal of Neuroimmune Pharmacology, published by Springer, is a premier academic journal dedicated to advancing the field of pharmacology intersecting with neuroscience and immunology. With an outstanding impact factor and proudly positioned in the Q1 quartile across multiple categories, this journal showcases cutting-edge research that enhances our understanding of the neuroimmune system and its pharmacological implications. Established in 2006 and continuing through 2024, it serves as a vital resource for researchers, professionals, and students alike, offering insights into the mechanisms of drug action, disease processes, and therapeutic strategies. As a testament to its excellence, the journal ranks prominently in Scopus metrics within its discipline, making it an essential platform for disseminating high-quality research that drives innovation in immunology, allergy, neuroscience, and pharmacology.

INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

Advancing Immunology and Pharmacology for a Healthier Tomorrow.
Publisher: SAGE PUBLICATIONS INCISSN: 0394-6320Frequency: 1 issue/year

Welcome to the International Journal of Immunopathology and Pharmacology, a premier publication dedicated to advancing the fields of immunology and pharmacology. Published by SAGE Publications Inc., this Open Access journal has been a vital resource since its inception in 1989, providing an expansive platform for innovative research and comprehensive reviews until 2024. With a strong focus on the mechanisms of immune responses and therapeutic developments, our journal stands out with a 2023 impact factor reflected in its Q3 ranking in Immunology and Allergy, and a Q2 ranking in Pharmacology. The journal's Scopus rankings highlight its significance, ranking #174 in Pharmacology, #141 in Medicine, and #156 in Immunology, all affirming its role in contributing to the broader scientific community. Through rigorous peer review and a commitment to high-quality research, the International Journal of Immunopathology and Pharmacology continues to be an essential resource for scientists, healthcare professionals, and students striving to enhance their knowledge and understanding in these critical fields.

Journal of Inflammation Research

Leading the Way in Inflammation Research and Therapeutics
Publisher: DOVE MEDICAL PRESS LTDISSN: Frequency: 1 issue/year

Journal of Inflammation Research, published by Dove Medical Press Ltd, is a premier open-access journal dedicated to advancing the field of immunology and allergy, with a particular focus on the biological mechanisms underlying inflammation. Since its inception in 2008, this journal has provided a vital platform for researchers to share their findings and foster collaboration within the global scientific community. With an impressive 2023 impact factor placing it in the Q2 category for both Immunology and Immunology and Allergy, the journal has consistently maintained its relevance and high academic standards, ranking #100 in Medicine (Immunology and Allergy) and #118 in Immunology (Immunology and Microbiology) according to Scopus metrics. The E-ISSN 1178-7031 allows for easy access to a plethora of pioneering research articles, reviews, and clinical studies that address contemporary issues in inflammation and immunity. As a leading resource for researchers, professionals, and students alike, Journal of Inflammation Research is committed to facilitating the dissemination of groundbreaking discoveries that contribute to improved therapeutic strategies and health outcomes.